Products & Services · Revenues:

Octagam — Revenues:

Pfizer Octagam — Revenues: increased by 1.7% to $122.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.6%, from $88.00M to $122.00M. Over 3 years (FY 2022 to FY 2025), Octagam — Revenues: shows an upward trend with a 31.0% CAGR.

Analysis

StatementSegment
First reportedQ1 2022
Last reportedQ1 2026May 5, 2026
Rolls up toTotal Revenue
Metric ID: pfe_segment_octagam_revenues

Historical Data

17 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$46.50M$46.50M$46.50M$46.50M$45.00M$66.00M$53.00M$81.00M$75.00M$104.00M$221.00M$109.00M$88.00M$97.00M$113.00M$120.00M$122.00M
QoQ Change—+0.0%+0.0%+0.0%-3.2%+46.7%-19.7%+52.8%-7.4%+38.7%+112.5%-50.7%-19.3%+10.2%+16.5%+6.2%+1.7%
YoY Change————-3.2%+41.9%+14.0%+74.2%+66.7%+57.6%+317.0%+34.6%+17.3%-6.7%-48.9%+10.1%+38.6%
Range$45.00M – $221.00M
CAGR+27.3%
Avg YoY Growth+47.2%
Median YoY Growth+34.6%
Current Streak4 quarters growth

Frequently Asked Questions

What is Pfizer's octagam — revenues:?
Pfizer (PFE) reported octagam — revenues: of $122.00M in Q1 2026.
How has Pfizer's octagam — revenues: changed year-over-year?
Pfizer's octagam — revenues: increased by 38.6% year-over-year, from $88.00M to $122.00M.
What is the long-term trend for Pfizer's octagam — revenues:?
Over 3 years (2022 to 2025), Pfizer's octagam — revenues: has grown at a 31.0% compound annual growth rate (CAGR), from $186.00M to $418.00M.